202 related articles for article (PubMed ID: 6603674)
1. Complement and the damaging effects of cardiopulmonary bypass.
Westaby S
Thorax; 1983 May; 38(5):321-5. PubMed ID: 6603674
[No Abstract] [Full Text] [Related]
2. The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass.
Tennenberg SD; Bailey WW; Cotta LA; Brodt JK; Solomkin JS
Surgery; 1986 Aug; 100(2):134-42. PubMed ID: 3738745
[TBL] [Abstract][Full Text] [Related]
3. [Activation of complement during cardiopulmonary bypass--comparative study using 4 different oxygenators].
Soejima K; Koyanagi H; Endo M; Hashimoto A; Imai Y
Nihon Kyobu Geka Gakkai Zasshi; 1987 Feb; 35(2):200-4. PubMed ID: 3495614
[No Abstract] [Full Text] [Related]
4. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.
Chenoweth DE; Cooper SW; Hugli TE; Stewart RW; Blackstone EH; Kirklin JW
N Engl J Med; 1981 Feb; 304(9):497-503. PubMed ID: 7453783
[TBL] [Abstract][Full Text] [Related]
5. Cardiac anaphylaxis. Complement activation as an amplification system.
del Balzo U; Polley MJ; Levi R
Circ Res; 1989 Sep; 65(3):847-57. PubMed ID: 2475275
[TBL] [Abstract][Full Text] [Related]
6. Complement ligand-receptor interactions that mediate biological responses.
Fearon DT; Wong WW
Annu Rev Immunol; 1983; 1():243-71. PubMed ID: 6242465
[No Abstract] [Full Text] [Related]
7. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease.
Belmont HM; Hopkins P; Edelson HS; Kaplan HB; Ludewig R; Weissmann G; Abramson S
Arthritis Rheum; 1986 Sep; 29(9):1085-9. PubMed ID: 3489467
[TBL] [Abstract][Full Text] [Related]
8. Interaction between the coagulation and complement system.
Amara U; Rittirsch D; Flierl M; Bruckner U; Klos A; Gebhard F; Lambris JD; Huber-Lang M
Adv Exp Med Biol; 2008; 632():71-9. PubMed ID: 19025115
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the immune response by anaphylatoxins.
Morgan EL
Complement; 1986; 3(3):128-36. PubMed ID: 3542364
[TBL] [Abstract][Full Text] [Related]
10. Time for new concepts about measurement of complement activation by cardiopulmonary bypass?
Videm V; Fosse E; Mollnes TE; Garred P; Svennevig JL
Ann Thorac Surg; 1992 Oct; 54(4):725-31. PubMed ID: 1417231
[TBL] [Abstract][Full Text] [Related]
11. The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution.
Moore FD; Warner KG; Assousa S; Valeri CR; Khuri SF
Ann Surg; 1988 Jul; 208(1):95-103. PubMed ID: 3260474
[TBL] [Abstract][Full Text] [Related]
12. Anaphylatoxins inhibit C2 production.
Lappin D; Damerau B; Whaley K
Clin Exp Immunol; 1983 Nov; 54(2):455-60. PubMed ID: 6317240
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the anaphylatoxin inactivator and chemotactic factor inactivator activities during cardiopulmonary bypass.
Kreutzer DL; McCormick JR; Despins A; Moore M; Rousou JH; Dobbs W; Engleman RN
J Exp Pathol; 1984; 1(3):183-7. PubMed ID: 6336305
[TBL] [Abstract][Full Text] [Related]
14. Anaphylatoxin-mediated regulation of human and murine immune responses.
Morgan EL; Weigle WO; Hugli TE
Fed Proc; 1984 Jul; 43(10):2543-7. PubMed ID: 6610569
[TBL] [Abstract][Full Text] [Related]
15. Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators.
Cavarocchi NC; Pluth JR; Schaff HV; Orszulak TA; Homburger HA; Solis E; Kaye MP; Clancy MS; Kolff J; Deeb GM
J Thorac Cardiovasc Surg; 1986 Feb; 91(2):252-8. PubMed ID: 3511328
[TBL] [Abstract][Full Text] [Related]
16. Anaphylatoxins: possible roles in disease.
Vogt W
Complement; 1986; 3(3):177-88. PubMed ID: 3026724
[TBL] [Abstract][Full Text] [Related]
17. Regulation of immune response by components of the complement cascade and their activated fragments.
Weigle WO; Goodman MG; Morgan EL; Hugli TE
Springer Semin Immunopathol; 1983; 6(2-3):173-94. PubMed ID: 6356429
[No Abstract] [Full Text] [Related]
18. Terminal complement complexes and anaphylatoxins in septic and ischemic patients.
Heideman M; Norder-Hansson B; Bengtson A; Mollnes TE
Arch Surg; 1988 Feb; 123(2):188-92. PubMed ID: 3277584
[TBL] [Abstract][Full Text] [Related]
19. Anaphylatoxin formation in extracorporeal circuits.
Chenoweth DE
Complement; 1986; 3(3):152-65. PubMed ID: 3492330
[TBL] [Abstract][Full Text] [Related]
20. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
